North America IVD Raw Materials Market Size, Share & Trends Analysis Report By Product (Antibody, Antigens, Proteins, Enzymes, Biological Buffers, Substrates, Others), By Technology (Molecular Diagnostics, Clinical Chemistry, Immunochemistry, Others), By End User (Diagnostic Laboratories, Pharmaceutical & Biotechnological Companies, Others) and By Country (U.S., Canada) Forecasts, 2026-2034

North America Ivd Raw Materials Market Size

The North America IVD Raw Materials Market size was valued at USD 6.91 billion in 2025 and is projected to grow from USD 7.41 billion in 2026 to reach USD 12.99 billion by 2034, growing at a CAGR of 7.3% during the forecast period 2026–2034.

The increasing focus on personalized medicine, advancements in diagnostic tools, and the rising prevalence of chronic diseases are significant factors propelling the market's growth in the region. Additionally, advancements in diagnostic technologies, rising disease prevalence, and increasing R&D activities further influence the development.

North America Ivd Raw Materials Market segmentation Analysis

By Product Type

Antibody dominates the product type segment and is expected to grow at a CAGR of 12.0% over the forecast period. In North America, the demand for monoclonal and polyclonal antibodies is expected to grow due to increased testing volumes in hospitals and laboratories, driven by rising disease prevalence and aging populations. Furthermore, expanding antibody-based tests in cancer diagnostics, such as immunohistochemistry (IHC), contributes to market growth.

Request Customizationto receive a tailored report.

By Technology

Immunochemistry dominates the technology segment and is expected to grow at a CAGR of 12.4%. The growing adoption of immunochemistry in point-of-care testing and home diagnostics is significantly boosting the market in North America. The region's advancements in automated platforms and reagent systems, aimed at reducing diagnostic time, further fuel this segment's growth. Innovations like chemiluminescence immunoassays (CLIA) have gained traction due to their high sensitivity and precision.

By End User

Pharmaceutical and biotechnological companies dominate the end-user category and is expected to grow at a CAGR of 12.9% during the forecast period. The increasing demand for precision medicine and targeted therapies in North America drives collaboration between diagnostic manufacturers and pharma companies. This trend is powerful in the U.S., where the focus on personalized medicine and immuno-oncology research has grown exponentially, leading to higher usage of IVD raw materials in drug development and clinical trials.

Speak to an Analystto discuss market opportunities.

North America Ivd Raw Materials Market Regional Insights

The market is characterized by significant regional variations, driven by diverse healthcare systems and infrastructure across North America. It is primarily driven by the number of annual diagnostic tests, which amounts to approximately 3.3 billion, and a demographic shift toward an aging population.

• The U.S. dominates the market, driven by robust healthcare infrastructure and substantial investment in diagnostic R&D. The country’s focus on precision medicine and advanced diagnostics has spurred demand for high-quality IVD materials. The U.S. also leads in regulatory frameworks for IVD products, encouraging innovation while maintaining stringent safety standards.
• Canada is experiencing steady growth in the IVD raw materials market, mainly due to government healthcare initiatives and rising healthcare expenditure. The demand for early diagnostic solutions, especially in cancer and infectious diseases, drives the need for specialized raw materials, particularly antibodies and molecular reagents.
• In Mexico, the market for IVD raw materials is expanding due to increasing healthcare awareness and improvements in medical infrastructure. The government's efforts to enhance healthcare access and invest in diagnostic technologies contribute to market growth. The rising prevalence of chronic diseases is also boosting demand for early detection tools, particularly in rural areas.
• Argentina’s market is growing due to increased healthcare spending and improvements in laboratory infrastructure. The country’s growing focus on disease surveillance and public health campaigns drives the demand for IVD diagnostic tools, increasing the need for raw materials like antigens and enzymes.
• Colombia is emerging as a promising market, driven by healthcare reforms to improve access to diagnostics. The growing incidence of chronic diseases and infectious outbreaks, such as dengue, has highlighted the need for better diagnostic capabilities, increasing the demand for IVD raw materials.

List of Key and Emerging Players in North America IVD Raw Materials Market